Onishi M, Kurozumi K, Ichikawa T, Michiue H, Fujii K, Ishida J, Shimazu Y, Chiocca EA, Kaur B, Date IGene expression profiling of the anti-glioma effect of Cilengitide.Springerplus 2(1) 160 12/1/2013
Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, Fernandez S, Kaur B, Rivera A, Oglesbee M, Cook C, Chiocca EA, Kwon CHCytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations.Cancer Res 73(11) 3441-50 6/1/2013
Currier MA, Eshun FK, Sholl A, Chernoguz A, Crawford K, Divanovic S, Boon L, Goins WF, Frischer JS, Collins MH, Leddon JL, Baird WH, Haseley A, Streby KA, Wang PY, Hendrickson BW, Brekken RA, Kaur B, Hildeman D, Cripe TPVEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.Mol Ther 21(5) 1014-23 5/1/2013
Meisen WH, Kaur BHow can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?Expert Rev Neurother 13(4) 341-3 4/1/2013
Onishi M, Ichikawa T, Kurozumi K, Fujii K, Yoshida K, Inoue S, Michiue H, Chiocca EA, Kaur B, Date IBimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models.Neuropathology 33(2) 162-74 4/1/2013
Uchida H, Marzulli M, Nakano K, Goins WF, Chan J, Hong CS, Mazzacurati L, Yoo JY, Haseley A, Nakashima H, Baek H, Kwon H, Kumagai I, Kuroki M, Kaur B, Chiocca EA, Grandi P, Cohen JB, Glorioso JCEffective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.Mol Ther 21(3) 561-9 3/1/2013
Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, He S, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, Moretta A, Caligiuri MA, Chiocca EANK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.Nat Med 18(12) 1827-34 12/1/2012
Gatson N, Chiocca EA, Kaur BAnti-angiogenic gene therapy in the treatment of malignant gliomas.Neurosci Lett 527(2) 62-70 10/11/2012
Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge C, Yu JG, Powell K, Mazar AP, Teknos TN, Old M, Glorioso JC, Chiocca EA, Kaur BCopper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.Clin Cancer Res 18(18) 4931-41 9/15/2012
Kaur B, Chiocca EA, Cripe TPOncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.Curr Pharm Biotechnol 13(9) 1842-51 7/1/2012
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CMMicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.Proc Natl Acad Sci U S A 109(14) 5316-21 4/3/2012
Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, Nowicki MO, Ha YP, Bergin S, Hwang C, Fernandez SA, Kaur B, Caligiuri MA, Chiocca EAThe histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.J Virol 86(8) 4566-77 4/1/2012
Haseley A, Boone S, Wojton J, Yu L, Yoo JY, Yu J, Kurozumi K, Glorioso JC, Caligiuri MA, Kaur BExtracellular matrix protein CCN1 limits oncolytic efficacy in glioma.Cancer Res 72(6) 1353-62 3/15/2012
Yoo JY, Haseley A, Bratasz A, Chiocca EA, Zhang J, Powell K, Kaur BAntitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus.Mol Ther 20(2) 287-97 2/1/2012
Alvarez-Breckenridge CA, Yu J, Kaur B, Caligiuri MA, Chiocca EADeciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells.Adv Virol 2012 702839 1/1/2012
Chiocca EA, Aguilar LK, Bell SD, Kaur B, Hardcastle J, Cavaliere R, McGregor J, Lo S, Ray-Chaudhuri A, Chakravarti A, Grecula J, Newton H, Harris KS, Grossman RG, Trask TW, Baskin DS, Monterroso C, Manzanera AG, Aguilar-Cordova E, New PZPhase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.J Clin Oncol 29(27) 3611-9 9/20/2011
Williams SP, Nowicki MO, Liu F, Press R, Godlewski J, Abdel-Rasoul M, Kaur B, Fernandez SA, Chiocca EA, Lawler SEIndirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.Cancer Res 71(16) 5374-80 8/15/2011